Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kovin Naidoo is active.

Publication


Featured researches published by Kovin Naidoo.


The Lancet Global Health | 2013

Causes of vision loss worldwide, 1990-2010: a systematic analysis

Rupert Bourne; Gretchen A Stevens; Richard A. White; Jennifer L. Smith; Seth R. Flaxman; Holly Price; Jost B. Jonas; Jill E. Keeffe; Janet Leasher; Kovin Naidoo; Konrad Pesudovs; Serge Resnikoff; Hugh R. Taylor

BACKGROUND Data on causes of vision impairment and blindness are important for development of public health policies, but comprehensive analysis of change in prevalence over time is lacking. METHODS We did a systematic analysis of published and unpublished data on the causes of blindness (visual acuity in the better eye less than 3/60) and moderate and severe vision impairment ([MSVI] visual acuity in the better eye less than 6/18 but at least 3/60) from 1980 to 2012. We estimated the proportions of overall vision impairment attributable to cataract, glaucoma, macular degeneration, diabetic retinopathy, trachoma, and uncorrected refractive error in 1990-2010 by age, geographical region, and year. FINDINGS In 2010, 65% (95% uncertainty interval [UI] 61-68) of 32·4 million blind people and 76% (73-79) of 191 million people with MSVI worldwide had a preventable or treatable cause, compared with 68% (95% UI 65-70) of 31·8 million and 80% (78-83) of 172 million in 1990. Leading causes worldwide in 1990 and 2010 for blindness were cataract (39% and 33%, respectively), uncorrected refractive error (20% and 21%), and macular degeneration (5% and 7%), and for MSVI were uncorrected refractive error (51% and 53%), cataract (26% and 18%), and macular degeneration (2% and 3%). Causes of blindness varied substantially by region. Worldwide and in all regions more women than men were blind or had MSVI due to cataract and macular degeneration. INTERPRETATION The differences and temporal changes we found in causes of blindness and MSVI have implications for planning and resource allocation in eye care. FUNDING Bill & Melinda Gates Foundation, Fight for Sight, Fred Hollows Foundation, and Brien Holden Vision Institute.


Archives of Ophthalmology | 2008

Global vision impairment due to uncorrected presbyopia.

Brien A. Holden; Timothy R. Fricke; S. May Ho; Reg Wong; Gerhard Schlenther; Sonja Cronjé; Anthea Burnett; Eric B. Papas; Kovin Naidoo; Kevin D. Frick

OBJECTIVES To evaluate the personal and community burdens of uncorrected presbyopia. METHODS We used multiple population-based surveys to estimate the global presbyopia prevalence, the spectacle coverage rate for presbyopia, and the community perception of vision impairment caused by uncorrected presbyopia. For planning purposes, the data were extrapolated for the future using population projections extracted from the International Data Base of the US Census Bureau. RESULTS It is estimated that there were 1.04 billion people globally with presbyopia in 2005, 517 million of whom had no spectacles or inadequate spectacles. Of these, 410 million were prevented from performing near tasks in the way they required. Vision impairment from uncorrected presbyopia predominantly exists (94%) in the developing world. CONCLUSIONS Uncorrected presbyopia causes widespread, avoidable vision impairment throughout the world. Alleviation of this problem requires a substantial increase in the number of personnel trained to deliver appropriate eye care together with the establishment of sustainable, affordable spectacle delivery systems in developing countries. In addition, given that people with presbyopia are at higher risk for permanently sight-threatening conditions such as glaucoma and diabetic eye disease, primary eye care should include refraction services as well as detection and appropriate referral for these and other such conditions.


Ophthalmology | 2013

Global Prevalence of Vision Impairment and Blindness: Magnitude and Temporal Trends, 1990–2010

Gretchen A Stevens; Richard A. White; Seth R. Flaxman; Holly Price; Jost B. Jonas; Jill E. Keeffe; Janet Leasher; Kovin Naidoo; Konrad Pesudovs; Serge Resnikoff; Hugh R. Taylor; Rupert Bourne

PURPOSE Vision impairment is a leading and largely preventable cause of disability worldwide. However, no study of global and regional trends in the prevalence of vision impairment has been carried out. We estimated the prevalence of vision impairment and its changes worldwide for the past 20 years. DESIGN Systematic review. PARTICIPANTS A systematic review of published and unpublished population-based data on vision impairment and blindness from 1980 through 2012. METHODS Hierarchical models were fitted fitted to estimate the prevalence of moderate and severe vision impairment (MSVI; defined as presenting visual acuity <6/18 but ≥ 3/60) and the prevalence of blindness (presenting visual acuity <3/60) by age, country, and year. MAIN OUTCOME MEASURES Trends in the prevalence of MSVI and blindness for the period 1990 through 2010. RESULTS Globally, 32.4 million people (95% confidence interval [CI], 29.4-36.5 million people; 60% women) were blind in 2010, and 191 million people (95% CI, 174-230 million people; 57% women) had MSVI. The age-standardized prevalence of blindness in older adults (≥ 50 years) was more than 4% in Western Sub-Saharan Africa (6.0%; 95% CI, 4.6%-7.1%), Eastern Sub-Saharan Africa (5.7%; 95% CI, 4.4%-6.9%), South Asia (4.4%; 95% CI, 3.5%-5.1%), and North Africa and the Middle East (4.6%; 95% CI, 3.5%-5.8%), in contrast to high-income regions with blindness prevalences of ≤ 0.4% or less. The MSVI prevalence in older adults was highest in South Asia (23.6%; 95% CI, 19.4%-29.4%), Oceania (18.9%; 95% CI, 11.8%-23.7%), and Eastern and Western Sub-Saharan Africa and North Africa and the Middle East (95% CI, 15.9%-16.8%). The MSVI prevalence was less than 5% in all 4 high-income regions. The global age-standardized prevalence of blindness and MSVI for older adults decreased from 3.0% (95% CI, 2.7%-3.4%) worldwide in 1990 to 1.9% (95% CI, 1.7%-2.2%) in 2010 and from 14.3% (95% CI, 12.1%-16.2%) worldwide to 10.4% (95% CI, 9.5%-12.3%), respectively. When controlling for age, womens prevalence of blindness was greater than mens in all world regions. Because the global population has increased and aged between 1990 and 2010, the number of blind has increased by 0.6 million people (95% CI, -5.2 to 5.3 million people). The number with MSVI may have increased by 19 million people (95% CI, -8 to 72 million people) from 172 million people (95% CI, 142-198 million people) in 1990. CONCLUSIONS The age-standardized prevalence of blindness and MSVI has decreased in the past 20 years. However, because of population growth and the relative increase in older adults, the blind population has been stable and the population with MSVI may have increased


British Journal of Ophthalmology | 2014

Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe: 1990–2010

Rupert Bourne; Jost B. Jonas; Seth R. Flaxman; Jill E. Keeffe; Janet Leasher; Kovin Naidoo; Maurizio Battaglia Parodi; Konrad Pesudovs; Holly Price; Richard A. White; Tien Yin Wong; Serge Resnikoff; Hugh R. Taylor

Background To assess prevalence and causes of blindness and vision impairment in high-income regions and in Central/Eastern Europe in 1990 and 2010. Methods Based on a systematic review of medical literature, prevalence of moderate and severe vision impairment (MSVI; presenting visual acuity <6/18 but ≥3/60 in the better eye) and blindness (presenting visual acuity <3/60) was estimated for 1990 and 2010. Results Age-standardised prevalence of blindness and MSVI decreased from 0.2% to 0.1% (3.314 million to 2.736 million people) and from 1.6% to 1.0% (25.362 million to 22.176 million), respectively. Women were generally more affected than men. Cataract was the most frequent cause of blindness in all subregions in 1990, but macular degeneration and uncorrected refractive error became the most frequent causes of blindness in 2010 in all high-income countries, except for Eastern/Central Europe, where cataract remained the leading cause. Glaucoma and diabetic retinopathy were fourth and fifth most common causes for blindness for all regions at both times. Uncorrected refractive error, followed by cataract, macular degeneration, glaucoma and diabetic retinopathy, was the most common cause for MSVI in 1990 and 2010. Conclusions In highly developed countries, prevalence of blindness and MSVI has been reduced by 50% and 38%, respectively, and the number of blind people and people with MSVI decreased by 17.4% and 12.6%, respectively, even with the increasing number of older people in the population. In high-income countries, macular degeneration has become the most important cause of blindness, but uncorrected refractive errors continue to be the leading cause of MSVI.


Bulletin of The World Health Organization | 2009

Potential lost productivity resulting from the global burden of uncorrected refractive error

T. S. T. Smith; Kevin D. Frick; Brien Holden; T. R. Fricke; Kovin Naidoo

OBJECTIVE To estimate the potential global economic productivity loss associated with the existing burden of visual impairment from uncorrected refractive error (URE). METHODS Conservative assumptions and national population, epidemiological and economic data were used to estimate the purchasing power parity-adjusted gross domestic product (PPP-adjusted GDP) loss for all individuals with impaired vision and blindness, and for individuals with normal sight who provide them with informal care. FINDINGS An estimated 158.1 million cases of visual impairment resulted from uncorrected or undercorrected refractive error in 2007; of these, 8.7 million were blind. We estimated the global economic productivity loss in international dollars (I


Investigative Ophthalmology & Visual Science | 2015

Number of People Blind or Visually Impaired by Cataract Worldwide and in World Regions, 1990 to 2010.

Moncef Khairallah; Rim Kahloun; Rupert Bourne; Hans Limburg; Seth R. Flaxman; Jost B. Jonas; Jill E. Keeffe; Janet Leasher; Kovin Naidoo; Konrad Pesudovs; Holly Price; Richard A. White; Tien Yin Wong; Serge Resnikoff; Hugh R. Taylor

) associated with this burden at I


Diabetes Care | 2016

Global Estimates on the Number of People Blind or Visually Impaired by Diabetic Retinopathy: A Meta-analysis From 1990 to 2010

Janet Leasher; Rupert Bourne; Seth R. Flaxman; Jost B. Jonas; Jill E. Keeffe; Kovin Naidoo; Konrad Pesudovs; Holly Price; Richard A. White; Tien Yin Wong; Serge Resnikoff; Hugh R. Taylor

427.7 billion before, and I


Indian Journal of Ophthalmology | 2012

Uncorrected refractive errors.

Kovin Naidoo; Jyoti Jaggernath

268.8 billion after, adjustment for country-specific labour force participation and employment rates. With the same adjustment, but assuming no economic productivity for individuals aged > 50 years, we estimated the potential productivity loss at I


British Journal of Ophthalmology | 2014

Prevalence and causes of vision loss in sub-Saharan Africa: 1990-2010

Kovin Naidoo; Stephen Gichuhi; María-Gloria Basáñez; Seth R. Flaxman; Jost B. Jonas; Jill E. Keeffe; Janet Leasher; Konrad Pesudovs; Holly Price; Jennifer L. Smith; Hugo C. Turner; Richard A. White; Tien Yin Wong; Serge Resnikoff; Hugh R. Taylor; Rupert Bourne

121.4 billion. CONCLUSION Even under the most conservative assumptions, the total estimated productivity loss, in


Ophthalmic Epidemiology | 2013

New Systematic Review Methodology for Visual Impairment and Blindness for the 2010 Global Burden of Disease Study

Rupert Bourne; Holly Price; Hugh R. Taylor; Janet Leasher; Jill E. Keeffe; Julie Glanville; Pamela C. Sieving; Moncef Khairallah; Tien Yin Wong; Yingfeng Zheng; Anu Mathew; Suchitra Katiyar; Maya N. Mascarenhas; Gretchen A Stevens; Serge Resnikoff; Stephen Gichuhi; Kovin Naidoo; Diane Wallace; Steven M. Kymes; Colleen Peters; Konrad Pesudovs; Tasanee Braithwaite; Hans Limburg

I, associated with visual impairment from URE is approximately a thousand times greater than the global number of cases. The cost of scaling up existing refractive services to meet this burden is unknown, but if each affected individual were to be provided with appropriate eyeglasses for less than I

Collaboration


Dive into the Kovin Naidoo's collaboration.

Top Co-Authors

Avatar

Serge Resnikoff

University of New South Wales

View shared research outputs
Top Co-Authors

Avatar

Jill E. Keeffe

L V Prasad Eye Institute

View shared research outputs
Top Co-Authors

Avatar

Janet Leasher

Nova Southeastern University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Rupert Bourne

Anglia Ruskin University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Tien Yin Wong

National University of Singapore

View shared research outputs
Top Co-Authors

Avatar

Seth R. Flaxman

Carnegie Mellon University

View shared research outputs
Top Co-Authors

Avatar

James Loughman

Dublin Institute of Technology

View shared research outputs
Researchain Logo
Decentralizing Knowledge